scholarly journals THE SO-CALLED RHYTHMS OF GROWTH-ENERGY IN MOUSE CANCER

1908 ◽  
Vol 10 (3) ◽  
pp. 283-307 ◽  
Author(s):  
Gary N. Calkins

In conclusion we may summarize the above biological observations in a series of theses as follows: 1. Cancer cells differ from other epithelial cells in respect to: (a) Size relations of nucleus and cell body; (b) power of indefinitely continued division. 2. Cancer cells differ from embryonic cells in absence of: (a) power of differentiation; (b) power of coördination of parts to whole; (c) power of self-regulation and limit of growth. 3. The continued development of the cancer cells is subject to the following factors: (a) the inherent potential of division of the cancer cells. (b) The natural resistance of the inoculated animals. The latter factor is usually regarded as the index of malignancy of a tumor and is based upon the percentage of takes together with the period required to kill the mice. Our experiments, however, show that the percentage of takes is independent of the time factor, and indicate the presence of a third factor which may be described as (c) the potential of "infectivity" of the cancer cells. 4. The potential of infectivity of cancer cells is characterized by more or less regular rhythms; these must be distinguished from rhythms of growth energy of the cancer cells which in all probability occur within the individual mouse. Without the division energy of the cancer cell this infectivity is inoperative, hence it follows that the cause of the infectivity lies within the cancer cell or is constantly associated with it. 5. Cancer cells differ from epithelial cells by virtue of this potential of infectivity combined with that of division energy. There is reason to believe that the latter is due to the action of stimuli and not to the liberation of a restrained growth power of embryonic tissue. There is reason to doubt that an initial and discontinued stimulus is responsible for these attributes of the cancer cells. Certain benign tumors, or vegetable galls, may be due to the action of such initial stimuli, but in them there is no infectivity. Embryonic tumors, due to embryonic cells, have a high power of differentiation combined with their division energy, but there is no infectivity. Infectivity distinguishes all cancerous growths from normal epithelium and from benign tumors or teratomata. 6. The rhythms of infectivity of cancer cells, erroneously regarded as rhythms of growth energy by Bashford, Murray and Boyen, appearing as they do in successive batches of mice which we may legitimately assume to have like powers of resistance, must have their cause in the cancer cells themselves. These cells, therefore, must be equivalent to parasites, or else parasites are contained within or associated with them. 7. Upon any other hypothesis it is difficult to conceive of cells creating a continual stimulus to their own growth energy, and it is still more difficult to explain the rhythms of infectivity. 8. Many lines of evidence point to the presence of some possible organism within the cancer cell; some organism which, acting as does Plasmodiophora brassicæ within vegetable cells, underlies the infectivity of cancer cells and provides the stimulus for their continued proliferation. Upon such an assumption the numerous cases of cage infection find their explanation. 9. The various inclusions of the cancer cell which have been described as organisms have been disproved; yet the analogy of club root and the many filter experiments show that the cause of infection may lie within the cancer cell. It is conceivable that, like the yellow fever organism, such an incitant may be in the protoplasm and beyond our powers with the microscope to locate. 10. The spirochætes which we have found in mouse cancer may have something to do with this infectivity of cancer cells. They may be useful in preparing the "soil" in new mouse hosts and making it susceptible to cell growth; or they may have intracellular stages in their life history which are too minute to be seen. The rhythms of infectivity, finally, may be an expression of the vitality of these spirochætes or of the hypothetical ultra-microscopical organisms accompanying cancer cells.

Molecules ◽  
2018 ◽  
Vol 23 (11) ◽  
pp. 3021 ◽  
Author(s):  
Lei Xu ◽  
Shengnan Xiao ◽  
Weihui Yuan ◽  
Jiongmo Cui ◽  
Guangyue Su ◽  
...  

To increase the antitumor activity of ginsenosides and acetylsalicylic acid, acid hydrolysis products of Panaxnotoginseng saponin were used as raw materials to be combined with salicylic acid to obtain ginsenoside salicylic acid derivatives. All derivatives were assessed for anti-cancer activity. A total of 20 target compounds were designed and synthesized. The cytotoxic activity on five cancer cell lines, including human colon cancer (HT-29), gastric cancer (BGC-823), cervical cancer (Hela), human breast cancer (MCF-7), human lung cancer cells (A549), and two normal cancer cell lines (human gastric epithelial cells (GES-1), and human ovarian epithelial cells (IOSE144)) was evaluated following treatment with the compounds. The results showed that all compounds inhibited the growth of cancer cells. Compounds 1a, 3a, 7a, 1b, 2b, 3b and 8b showed strong anticancer activity. For MCF-7 cells, compound 3b showed the strongest inhibitory activity, IC50 = 2.56 ± 0.09 μM. In the cytotoxicity test, all compounds showed low toxicity or no toxicity (IC50 > 100 μM). In addition, a cell cycle distribution assay and wound healing assay demonstrated that compound 3b specifically inhibited MCF-7 proliferation and migration ability. Our results indicate that compound 3b represents a promising compound for further cancer studies.


2021 ◽  
Author(s):  
Daria S. Roshal ◽  
Marianne Martin ◽  
Kirill Fedorenko ◽  
Virginie MOLLE ◽  
Stephen Baghdiguian ◽  
...  

Although the polygonal shape of epithelial cells has drawn the attention of scientists for several centuries, only recently, it has been demonstrated that distributions of polygon types (DOPTs) are similar in proliferative epithelia of many different plant and animal species. In this study we show that hyper-proliferation of cancer cells disrupts this universality paradigm and results in random epithelial structures. Examining non-synchronized and synchronized HeLa cervix cells, we suppose that the cell size spread is the single parameter controlling the DOPT in these monolayers. We test this hypothesis by considering morphologically similar random polygonal packings. By analyzing the differences between tumoral and non-tumoral epithelial monolayers, we uncover that the latter have more ordered structures and argue that the relaxation of mechanical stresses associated with cell division induces more effective ordering in the epithelia with lower proliferation rates. The proposed theory also explains the specific highly ordered structures of some post-mitotic unconventional epithelia.


2020 ◽  
Vol 295 (40) ◽  
pp. 13737-13752 ◽  
Author(s):  
Kangdi Li ◽  
Ting Liu ◽  
Jie Chen ◽  
Huying Ni ◽  
Wenhua Li

Cancer-associated fibroblasts (CAFs) play a critical role in the coevolution of breast tumor cells and their microenvironment by modifying cellular compartments and regulating cancer cell functions via stromal-epithelial dialogue. However, the relationship and interaction between stromal and epithelial cells is still poorly understood. Herein, we revealed that breast cancer cells have a stronger ability to activate fibroblasts and transform them into myofibroblasts (CAF-like) than normal breast epithelial cells, and this stronger ability occurs through paracrine signaling. In turn, myofibroblasts promote the proliferation, epithelial-to-mesenchymal transition (EMT), and stemness of breast cancer cells. Detailed regulatory mechanisms showed that, compared with normal cells, Survivin is overexpressed in breast cancer cells and secreted extracellularly in the form of exosomes, which are then internalized by fibroblasts. Breast cancer cell–derived survivin up-regulates SOD1 expression in fibroblasts and then converts them into myofibroblasts, conversely inducing breast cancer progression in vitro and in vivo. Thus, our results indicate that survivin acts as an activator of the tumor microenvironment and that SOD1 up-regulation in fibroblasts can promote breast cancer progression. These results suggest that targeting survivin and SOD1 may be a potential therapeutic strategy for breast cancer.


Author(s):  
Kritika Saxena ◽  
Syamanthak Srikrishnan ◽  
Toni Celia-Terrassa ◽  
Mohit Kumar Jolly

OVOL proteins (OVOL1 and OVOL2), vertebrate homologs of Drosophila OVO, are critical regulators of epithelial lineage determination and differentiation during embryonic development in tissues such as kidney, skin, mammary epithelia, testis. OVOL inhibits EMT and can promote MET; moreover, they can regulate the stemness of cancer cells, thus playing an important role during cancer cell metastasis. Due to their central role in differentiation and maintenance of epithelial lineage, OVOL overexpression has been shown to be capable of reprogramming fibroblasts to epithelial cells. Here, we review the roles of OVOL mediated epithelial differentiation across multiple contexts – embryonic development, cancer progression, and cellular reprogramming.


2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Lisni Noraida Waruwu ◽  
Maria Bintang ◽  
Bambang Pontjo Priosoeryanto

Green tea (Camellia sinensis) is one of traditional plants that have the potential as an anticancer. The sample used in this research commercial green tea extract. The purpose of this study was to test the antiproliferation activity of green tea extract on breast cancer cell MCM-B2 in vitro. Green tea extract fractionated using three solvents, ie water, ethanol 70%, and n-hexane. Extract and fraction of green tea water have value Lethality Concentration 50 (LC50) more than 1000 ppm. The fraction of ethanol 70% and n-hexane had an LC50 value of 883.48 ppm and 600.56 ppm, respectively. The results of the phytochemical screening of green tea extract are flavonoids, tannins, and saponins, while the phytochemical screening results of n-hexane fraction are flavonoids and tannins. Antiproliferation activity was tested on breast cancer cells MCM-B2 and normal cells Vero by trypan blue staining method. The highest MCM-B2 cell inhibitory activity was achieved at a concentration of 13000 ppm green tea extract and 1000 ppm of n-hexane fraction, 59% and 59%, respectively. The extract and n-hexane fraction of green tea are not toxic to normal Vero cells characterized by not inhibiting normal cell proliferation. Keywords: antiproliferative, cancer cell MCM-B2, commercial green tea, cytotoxicity


2020 ◽  
Vol 20 (23) ◽  
pp. 2070-2079
Author(s):  
Srimadhavi Ravi ◽  
Sugata Barui ◽  
Sivapriya Kirubakaran ◽  
Parul Duhan ◽  
Kaushik Bhowmik

Background: The importance of inhibiting the kinases of the DDR pathway for radiosensitizing cancer cells is well established. Cancer cells exploit these kinases for their survival, which leads to the development of resistance towards DNA damaging therapeutics. Objective: In this article, the focus is on targeting the key mediator of the DDR pathway, the ATM kinase. A new set of quinoline-3-carboxamides, as potential inhibitors of ATM, is reported. Methods: Quinoline-3-carboxamide derivatives were synthesized and cytotoxicity assay was performed to analyze the effect of molecules on different cancer cell lines like HCT116, MDA-MB-468, and MDA-MB-231. Results: Three of the synthesized compounds showed promising cytotoxicity towards a selected set of cancer cell lines. Western Blot analysis was also performed by pre-treating the cells with quercetin, a known ATM upregulator, by causing DNA double-strand breaks. SAR studies suggested the importance of the electron-donating nature of the R group for the molecule to be toxic. Finally, Western-Blot analysis confirmed the down-regulation of ATM in the cells. Additionally, the PTEN negative cell line, MDA-MB-468, was more sensitive towards the compounds in comparison with the PTEN positive cell line, MDA-MB-231. Cytotoxicity studies against 293T cells showed that the compounds were at least three times less toxic when compared with HCT116. Conclusion: In conclusion, these experiments will lay the groundwork for the evolution of potent and selective ATM inhibitors for the radio- and chemo-sensitization of cancer cells.


2018 ◽  
Vol 18 (17) ◽  
pp. 1483-1493
Author(s):  
Ricardo Imbroisi Filho ◽  
Daniel T.G. Gonzaga ◽  
Thainá M. Demaria ◽  
João G.B. Leandro ◽  
Dora C.S. Costa ◽  
...  

Background: Cancer is a major cause of death worldwide, despite many different drugs available to treat the disease. This high mortality rate is largely due to the complexity of the disease, which results from several genetic and epigenetic changes. Therefore, researchers are constantly searching for novel drugs that can target different and multiple aspects of cancer. Experimental: After a screening, we selected one novel molecule, out of ninety-four triazole derivatives, that strongly affects the viability and proliferation of the human breast cancer cell line MCF-7, with minimal effects on non-cancer cells. The drug, named DAN94, induced a dose-dependent decrease in MCF-7 cells viability, with an IC50 of 3.2 ± 0.2 µM. Additionally, DAN94 interfered with mitochondria metabolism promoting reactive oxygen species production, triggering apoptosis and arresting the cancer cells on G1/G0 phase of cell cycle, inhibiting cell proliferation. These effects are not observed when the drug was tested in the non-cancer cell line MCF10A. Using a mouse model with xenograft tumor implants, the drug preventing tumor growth presented no toxicity for the animal and without altering biochemical markers of hepatic function. Results and Conclusion: The novel drug DAN94 is selective for cancer cells, targeting the mitochondrial metabolism, which culminates in the cancer cell death. In the end, DAN94 has been shown to be a promising drug for controlling breast cancer with minimal undesirable effects.


2020 ◽  
Vol 17 (11) ◽  
pp. 1330-1341
Author(s):  
Yan Zhang ◽  
Niefang Yu

Background: Fibroblast growth factors (FGFs) and their high affinity receptors (FGFRs) play a major role in cell proliferation, differentiation, migration, and apoptosis. Aberrant FGFR signaling pathway might accelerate development in a broad panel of malignant solid tumors. However, the full application of most existing small molecule FGFR inhibitors has become a challenge due to the potential target mutation. Hence, it has attracted a great deal of attention from both academic and industrial fields for hunting for novel FGFR inhibitors with potent inhibitory activities and high selectivity. Objective: Novel 5-amino-1H-pyrazole-1-carbonyl derivatives were designed, synthesized, and evaluated as FGFR inhibitors. Methods: A series of 5-amino-1H-pyrazole-1-carbonyl derivatives were established by a condensation of the suitable formyl acetonitrile derivatives with either hydrazine or hydrazide derivatives in the presence of anhydrous ethanol or toluene. The inhibitory activities of the target compounds were screened against the FGFRs and two representative cancer cell lines. Tests were carried out to observe the inhibition of 8e against FGFR phosphorylation and downstream signal phosphorylation in human gastric cancer cell lines (SNU-16). The molecular docking of all the compounds were performed using Molecular Operating Environment in order to evaluate their binding abilities with the corresponding protein kinase. Results: A series of 5-amino-1H-pyrazole-1-carbonyl derivatives have been designed and synthesized, screened for their inhibitory activities against FGFRs and cancer cell lines. Most of the target compounds showed moderate to good anti-proliferate activities against the tested enzymes and cell lines. The most promising compounds 8e suppressed FGFR1-3 with IC50 values of 56.4, 35.2, 95.5 nM, and potently inhibited the SNU-16 and MCF-7 cancer cells with IC50 values of 0.71 1.26 μM, respectively. And 8e inhibited the growth of cancer cells containing FGFR activated by multiple mechanisms. In addition, the binding interactions were quite similar in the molecular models between generated compounds and Debio-1347 with the FGFR1. Conclusion: According to the experimental findings, 5-amino-1H-pyrazole-1-carbonyl might serve as a promising template of an FGFR inhibitor.


2019 ◽  
Vol 15 (7) ◽  
pp. 738-742 ◽  
Author(s):  
Adnan Badran ◽  
Atia-tul-Wahab ◽  
Sharmeen Fayyaz ◽  
Elias Baydoun ◽  
Muhammad Iqbal Choudhary

Background:Breast cancer is the most prevalent cancer type in women globally. It is characterized by distinct subtypes depending on different gene expression patterns. Oncogene HER2 is expressed on the surface of cell and is responsible for cell growth regulation. Increase in HER2 receptor protein due to gene amplification, results in aggressive growth, and high metastasis in cancer cells.Methods:The current study evaluates and compares the anti-breast cancer effect of commercially available compounds against HER2 overexpressing BT-474, and triple negative MDA-MB-231 breast cancer cell lines.Results:Preliminary in vitro cell viability assays on these cell lines identified 6 lead molecules active against breast cancer. Convallatoxin (4), a steroidal lactone glycoside, showed the most potent activity with IC50 values of 0.63 ± 0.56, and 0.69 ± 0.59 µM against BT-474 and MDA-MB-231, respectively, whereas 4-[4-(Trifluoromethyl)-phenoxy] phenol (3) a phenol derivative, and Reserpine (5) an indole alkaloid selectively inhibited the growth of BT-474, and MDA-MB-231 breast cancer cells, respectively.Conclusion:These results exhibited the potential of small molecules in the treatment of HER2 amplified and triple negative breast cancers in vitro.


Sign in / Sign up

Export Citation Format

Share Document